Future synthetic drugs in Europe by 2050 - EUDA scenarios map how technology, markets, crime and health systems could shape novel substances and related risks

Synthetic drugs in Europe by 2050 are framed through forward-looking scenarios that connect chemical innovation, online distribution, organized crime, regulation, and public health. The focus is not a single substance but a changing ecosystem in which novel psychoactive compounds, new production methods, and digital markets could reshape drug availability and risk. The scenarios highlight how advances in biotechnology, automation, data systems, and consumer platforms may accelerate the appearance of new synthetic substances and complicate monitoring, enforcement, and harm reduction. They also point to shifts in supply chains, the role of transnational criminal networks, and pressure on early warning systems. European preparedness sits at the center of the publication. Policymakers, researchers, and health services are encouraged to use scenario planning to test responses, strengthen surveillance, and anticipate consequences for safety, regulation, and drug-related care before these futures become more immediate.